24 results on '"Nuciforo, Paolo"'
Search Results
2. Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
3. A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
4. RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer
5. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
6. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
7. Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
8. pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation
9. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
10. Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer
11. PI3K activation promotes resistance to eribulin in HER2-negative breast cancer
12. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
13. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
14. Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment
15. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
16. Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
17. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
18. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
19. Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic
20. The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
21. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
22. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours
23. Malakoplakia of the pancreas with diffuse lymph-node involvement
24. Erratum To: The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.